# IPSC (Century Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Century Therapeutics, Inc. reported $109.2M in revenue and a net loss of $98.82M for the fiscal year ended December 31, 2025 (up 1556.8% year over year), with a -97.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/IPSC
- Markdown: https://convexityos.com/fundamentals/IPSC.md
- SEC CIK: 0001850119
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:40 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001850119&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $109.2M | +1556.8% YoY |
| Operating Income | FY 2025 | -$106.1M | -97.2% margin |
| Net Income | FY 2025 | -$98.82M | -90.5% net margin |
| Diluted EPS | FY 2025 | -$0.48 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$85.08M | -77.9% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $117.2M | Total debt: $37.49M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $109.2M | $6.59M | $2.23M | $5.20M | -- | -- |
| Research & Development | $95.67M | $107.2M | $92.71M | $97.17M | $75.65M | $39.68M |
| Total Operating Expenses | $126.4M | $144.7M | $148.8M | $139.0M | $94.88M | $53.90M |
| **Operating Income** | -$17.27M | -$138.1M | -$146.5M | -$133.8M | -$94.88M | -$53.90M |
| **EBITDA** | -$4.17M | -$124.8M | -$133.5M | -$125.4M | -$91.14M | -$52.50M |
| Interest Income | $7.35M | $13.01M | $12.68M | -- | -- | -- |
| Interest Expense | -- | -- | $540K | $1.02M | $1.27M | $381K |
| Income Before Tax | -$9.65M | -$124.8M | -$134.8M | -$130.8M | -$95.78M | -$53.58M |
| Income Tax Expense | -$68K | $1.79M | $1.88M | $91K | $43K | -- |
| **Net Income** | -$9.58M | -$126.6M | -$136.7M | -$130.9M | -$95.82M | -$53.58M |
| Basic EPS | -$0.14 | -$1.61 | -$2.30 | -$2.27 | -$2.96 | -$7.16 |
| **Diluted EPS** | -$0.14 | -$1.61 | -$2.30 | -$2.96 | -$2.96 | -$7.16 |
| Basic Shares Outstanding | 86.6M | 78.6M | 59.3M | 57.8M | 32.4M | 7.5M |
| Diluted Shares Outstanding | 86.6M | 78.6M | 59.3M | 32.4M | 32.4M | 7.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $0 | $0 | $109.2M | $4.17M |
| Research & Development | $18.06M | $19.59M | $17.11M | $19.70M | $12K | $26.86M | $26.58M | $29.38M |
| Total Operating Expenses | $25.21M | $36.53M | $23.68M | $20.65M | $36.12M | $34.66M | $34.99M | $41.46M |
| **Operating Income** | -$25.21M | -$36.53M | -$23.68M | -$20.65M | -$36.12M | -$34.66M | $74.18M | -$37.28M |
| **EBITDA** | -$23.02M | -$36.50M | -$20.68M | -$17.10M | -$32.99M | -$31.46M | $77.40M | -$33.97M |
| Interest Income | $1.75M | $1.98M | $2.02M | $1.31M | $1.60M | $2.01M | $2.42M | $2.88M |
| Income Before Tax | -- | -- | -- | -$19.24M | -$34.42M | -$32.54M | $76.56M | -$34.30M |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | $1.78M |
| **Net Income** | -$23.45M | -$34.55M | -$21.64M | -$19.17M | -$34.42M | -$32.54M | $76.56M | -$36.07M |
| Basic EPS | -$0.11 | -$0.17 | -$0.11 | -- | -$0.40 | -$0.38 | $0.89 | -- |
| **Diluted EPS** | -$0.11 | -$0.17 | -$0.11 | -- | -$0.40 | -$0.38 | $0.89 | -- |
| Basic Shares Outstanding | 206.4M | 205.8M | 193.5M | -- | 86.5M | 86.2M | 86.0M | -- |
| Diluted Shares Outstanding | 206.4M | 205.8M | 193.5M | -- | 86.5M | 86.2M | 86.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $61.85M | $58.44M | $47.32M | $84.27M | $56.45M | $27.21M |
| Short-Term Investments | $55.26M | $130.9M | $125.4M | $231.2M | $166.4M | $48.54M |
| **Cash & Short-Term Investments** | $117.1M | $189.3M | $172.7M | $315.5M | $222.9M | $75.75M |
| Other Current Assets | -- | -- | $1.57M | -- | $250K | $256K |
| **Total Current Assets** | $120.8M | $194.1M | $177.0M | $319.7M | $228.2M | $78.80M |
| Property, Plant & Equipment, Net | $50.03M | $62.14M | $71.70M | $82.78M | $57.97M | $15.38M |
| Intangible Assets | $34.20M | $34.20M | -- | -- | -- | -- |
| Long-Term Investments | -- | $30.82M | $89.10M | $51.85M | $135.9M | $1.05M |
| **Total Non-Current Assets** | $102.9M | $159.2M | $183.7M | $166.8M | $209.2M | $27.98M |
| **Total Assets** | $223.7M | $353.2M | $360.7M | $486.5M | $437.4M | $106.8M |
| Accounts Payable | $4.77M | $3.08M | $2.74M | $5.45M | $7.60M | $8.08M |
| Deferred Revenue (Current) | -- | $109.2M | $4.37M | $7.15M | -- | -- |
| Other Current Liabilities | -- | $75K | $28K | $236K | -- | -- |
| **Total Current Liabilities** | $20.23M | $129.8M | $17.85M | $29.82M | $15.65M | $12.11M |
| Long-Term Debt | -- | -- | -- | $3.74M | $8.90M | $9.64M |
| Deferred Revenue (Non-Current) | -- | -- | $111.4M | $110.8M | -- | -- |
| **Total Non-Current Liabilities** | $44.54M | $62.07M | $158.1M | $154.0M | $25.48M | $21.32M |
| **Total Liabilities** | $64.77M | $191.9M | $175.9M | $183.8M | $41.14M | $33.43M |
| **Total Debt (incl. Leases)** | $43.56M | $53.83M | $48.17M | $49.41M | $25.12M | $21.55M |
| Common Stock | $9.0K | $9.0K | $6.0K | $6.0K | $5.0K | $1.0K |
| Retained Earnings | -$791.9M | -$782.3M | -$655.8M | -$519.1M | -$388.2M | -$292.3M |
| Accumulated Other Comp. Income | $30K | $324K | $108K | -$2.46M | -$650K | -$3.0K |
| **Total Stockholders' Equity** | $158.9M | $161.4M | $184.8M | $302.7M | $396.2M | -$106.4M |
| Total Equity | $158.9M | $161.4M | $184.8M | $302.7M | $396.2M | -$106.4M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $45.02M | $49.64M | $51.05M | $61.85M | $55.52M | $56.88M | $51.87M | $58.44M |
| Short-Term Investments | $72.19M | $70.07M | $83.75M | $55.26M | $77.23M | $98.97M | $113.3M | $130.9M |
| **Cash & Short-Term Investments** | $117.2M | $119.7M | $134.8M | $117.1M | $132.7M | $155.8M | $165.1M | $189.3M |
| **Total Current Assets** | $122.7M | $124.8M | $139.0M | $120.8M | $137.7M | $160.2M | $169.6M | $194.1M |
| Property, Plant & Equipment, Net | $32.83M | $34.48M | $47.61M | $50.03M | $53.72M | $56.65M | $59.53M | $62.14M |
| Intangible Assets | $34.20M | $34.20M | $34.20M | $34.20M | $34.20M | $34.20M | $34.20M | $34.20M |
| Long-Term Investments | $56.92M | $77.48M | $82.17M | -- | -- | $2.69M | $20.71M | $30.82M |
| **Total Non-Current Assets** | $139.9M | $162.2M | $187.5M | $102.9M | $107.0M | $124.5M | $146.0M | $159.2M |
| **Total Assets** | $262.6M | $287.0M | $326.6M | $223.7M | $244.7M | $284.7M | $315.6M | $353.2M |
| Accounts Payable | $2.98M | $4.82M | $3.15M | $4.77M | $2.62M | $3.21M | $3.57M | $3.08M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $109.2M |
| Other Current Liabilities | -- | -- | -- | -- | $1.03M | $49K | $111K | $75K |
| **Total Current Liabilities** | $14.04M | $15.07M | $13.57M | $20.23M | $22.03M | $14.95M | $14.50M | $129.8M |
| Other Non-Current Liabilities | $666K | $666K | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $38.61M | $39.59M | $48.24M | $44.54M | $46.34M | $59.85M | $60.67M | $62.07M |
| **Total Liabilities** | $52.66M | $54.66M | $61.81M | $64.77M | $68.37M | $74.79M | $75.17M | $191.9M |
| **Total Debt (incl. Leases)** | $37.49M | $38.67M | $48.02M | $43.56M | $44.96M | $51.48M | $52.67M | $53.83M |
| Common Stock | $18K | $18K | $18K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K |
| Retained Earnings | -$871.6M | -$848.1M | -$813.6M | -$791.9M | -$772.7M | -$738.3M | -$705.8M | -$782.3M |
| Accumulated Other Comp. Income | -$1.14M | -$694K | -$585K | $30K | $64K | $83K | $305K | $324K |
| **Total Stockholders' Equity** | $210.0M | $232.3M | $264.7M | $158.9M | $176.3M | $209.9M | $240.4M | $161.4M |
| Total Equity | $210.0M | $232.3M | $264.7M | $158.9M | $176.3M | $209.9M | $240.4M | $161.4M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$9.58M | -$126.6M | -$136.7M | -$130.9M | -$95.82M | -$53.58M |
| Depreciation & Amortization | $13.10M | $13.30M | $13.04M | $8.44M | $3.75M | $1.40M |
| Stock-Based Compensation | $6.84M | $12.69M | $14.62M | $10.67M | $4.66M | $876K |
| Change in Payables | $1.56M | -$1.47M | -$2.36M | -$4.79M | -$1.85M | $2.06M |
| **Operating Cash Flow** | -$103.9M | -$110.1M | -$88.35M | $14.05M | -$89.00M | -$41.27M |
| Capital Expenditure | -$848K | -$154K | -$13.74M | -$30.60M | -$44.97M | -$9.82M |
| **Free Cash Flow** | -$104.7M | -$110.3M | -$102.1M | -$16.55M | -$134.0M | -$51.09M |
| Purchases of Investments | -$51.17M | -$119.5M | -$209.0M | -$254.0M | -$330.0M | -$49.86M |
| **Investing Cash Flow** | $107.5M | $47.48M | $61.13M | -$13.13M | -$298.3M | -$22.76M |
| Common Stock Issued | $173K | $141K | $516K | $345K | $213K | -- |
| **Financing Cash Flow** | $173K | $74.56M | -$9.72M | $27.16M | $417.8M | $47.69M |
| **Net Change in Cash** | $3.80M | $11.91M | -$36.94M | $28.08M | $30.43M | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$23.45M | -$34.55M | -$21.64M | -$19.17M | -$34.43M | -$32.54M | $76.56M | -$36.07M |
| Depreciation & Amortization | $2.19M | $26K | $3.00M | $3.55M | $3.13M | $3.20M | $3.22M | $3.32M |
| Stock-Based Compensation | $1.44M | $1.95M | $1.45M | $1.30M | $892K | $2.22M | $2.43M | $2.66M |
| Change in Payables | -$1.84M | $1.67M | -$1.62M | $2.16M | -$591K | -$365K | $361K | $477K |
| **Operating Cash Flow** | -$22.23M | -$19.83M | -$25.26M | -$16.08M | -$25.58M | -$27.59M | -$34.62M | -$24.22M |
| Capital Expenditure | -$535K | -$694K | -$584K | $139K | -$195K | -$317K | -$475K | -- |
| **Free Cash Flow** | -$22.76M | -$20.53M | -$25.85M | -$15.94M | -$25.78M | -$27.91M | -$35.10M | -- |
| Purchases of Investments | -$1.31M | -$15.97M | -$140.7M | -$15.60M | -$11.02M | -$9.67M | -$14.88M | -$17.40M |
| **Investing Cash Flow** | $17.53M | $17.77M | -$112.6M | $22.36M | $24.67M | $32.54M | $27.93M | $30.61M |
| Common Stock Issued | $76K | $347K | $202K | $53K | $0 | $0 | $120K | -$602K |
| **Financing Cash Flow** | $76K | $311K | $126.6M | $53K | $0 | $0 | $120K | -$602K |
| **Net Change in Cash** | -$4.63M | -$1.76M | -$11.25M | $6.34M | -$913K | $4.95M | -$6.57M | $5.78M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -15.8% | -2096.5% | -6556.9% | -2574.2% | -- | -- |
| **Net Profit Margin** | -8.8% | -1920.9% | -6115.1% | -2518.4% | -- | -- |
| Return on Equity (ROE) | -6.0% | -78.4% | -74.0% | -43.2% | -24.2% | -- |
| Return on Assets (ROA) | -4.3% | -35.8% | -37.9% | -26.9% | -21.9% | -50.2% |
| Current Ratio | 5.97x | 1.50x | 9.92x | 10.72x | 14.57x | 6.51x |
| Quick Ratio | 5.79x | 1.46x | 9.68x | 10.58x | 14.24x | 6.25x |
| Debt to Equity | 0.27x | 0.33x | 0.26x | 0.16x | 0.06x | -- |
| **Revenue Growth (YoY)** | +1556.8% | +194.8% | -57.0% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -728.7% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -15.8% | -29.9% | -28.5% | -28.4% | -2096.2% |
| **Net Profit Margin** | -- | -- | -- | -8.8% | -23.4% | -20.4% | -19.1% | -1920.6% |
| Return on Equity (ROE) | -47.1% | -47.3% | -40.7% | -6.0% | -15.0% | -11.1% | -9.1% | -78.4% |
| Return on Assets (ROA) | -37.6% | -38.3% | -33.0% | -4.3% | -10.8% | -8.2% | -7.0% | -35.8% |
| Current Ratio | 8.74x | 8.28x | 10.25x | 5.97x | 6.25x | 10.72x | 11.70x | 1.50x |
| Quick Ratio | 8.34x | 7.94x | 9.94x | 5.79x | 6.03x | 10.43x | 11.39x | 1.46x |
| Debt to Equity | 0.18x | 0.17x | 0.18x | 0.27x | 0.25x | 0.25x | 0.22x | 0.33x |
| **Revenue Growth (YoY)** | -- | -- | -- | -100.0% | -100.0% | -100.0% | +12667.7% | +1457.1% |
| Operating Income Growth (YoY) | -- | -- | -131.9% | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -128.3% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -112.4% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
